Allspring Global Investments’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-69,021
| Closed | -$317K | – | 1807 |
|
|
2025
Q1 | $317K | Sell |
69,021
-4,837
| -7% | -$22.2K | ﹤0.01% | 1571 |
|
|
2024
Q4 | $354K | Sell |
73,858
-77,738
| -51% | -$372K | ﹤0.01% | 1544 |
|
|
2024
Q3 | $711K | Buy |
151,596
+168
| +0.1% | +$788 | ﹤0.01% | 1400 |
|
|
2024
Q2 | $856K | Sell |
151,428
-9,043
| -6% | -$51.1K | ﹤0.01% | 1370 |
|
|
2024
Q1 | $660K | Sell |
160,471
-90,666
| -36% | -$373K | ﹤0.01% | 1463 |
|
|
2023
Q4 | $1.06M | Sell |
251,137
-62,482
| -20% | -$264K | ﹤0.01% | 1328 |
|
|
2023
Q3 | $1.35M | Buy |
313,619
+113,139
| +56% | +$489K | ﹤0.01% | 1291 |
|
|
2023
Q2 | $1.32M | Sell |
200,480
-596,912
| -75% | -$3.93M | ﹤0.01% | 1344 |
|
|
2023
Q1 | $5.41M | Buy |
797,392
+565,510
| +244% | +$3.84M | 0.01% | 969 |
|
|
2022
Q4 | $1.71M | Buy |
231,882
+39,918
| +21% | +$295K | ﹤0.01% | 1286 |
|
|
2022
Q3 | $1.9M | Buy |
191,964
+189,173
| +6,778% | +$1.87M | ﹤0.01% | 1245 |
|
|
2022
Q2 | $30K | Sell |
2,791
-81,005
| -97% | -$871K | ﹤0.01% | 2397 |
|
|
2022
Q1 | $947K | Sell |
83,796
-17,181
| -17% | -$194K | ﹤0.01% | 1908 |
|
|
2021
Q4 | $1.58M | Buy |
+100,977
| New | +$1.58M | ﹤0.01% | 1669 |
|